Future of Cancer Science and Medicine Beyond COVID-19
In this section you will learn: COVID-19 accelerated adoption of telemedicine across the cancer care continuum. Lessons learned from...
The Honorable Roy Blunt: Investing in Innovation to Respond to COVID-19 and Continue Progress against Cancer
U.S. Senator for MissouriAge 72 There is no question we are at an exciting moment for health research. In...
Virtual Congressional Briefing: AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
The American Association for Cancer Research (AACR) will host a virtual briefing to unveil the AACR Report on the Impact...
Julie Campbell: Fighting COVID-19 While Undergoing Treatment for Breast Cancer
Age 64Vineland, New Jersey In October of 2020, Julie Campbell, a real estate professional from New Jersey and a...
Executive Summary
The Coronavirus Disease 2019 (COVID-19) pandemic has disrupted the everyday lives of billions of people, exhausted the health care...
COVID-19 Policy and Procedures
AACR Policy and Procedures Last updated March 29, 2023 The health and safety of AACR meeting/conference participants, as well...
COVID-19 and Cancer Task Force
Task Force Charge Task Force Members Dafna Bar-Sagi, PhD, FAACRSenior Vice President and Vice Dean for ScienceChief Scientific Officer,...
Federico de Armas Heinzen: Managing Metastatic Melanoma Despite an Interruption in Treatment Because of COVID-19
Age 51Mexico City, Mexico In 2015, Federico de Armas Heinzen felt a swollen lymph node under his right arm...
A Message from the AACR
This is an uncertain time for everyone around the world, including those of us working in the field of...
Coronavirus Information and Resources
The coronavirus outbreak that has been declared a pandemic by the World Health Organization is affecting people throughout the United...
Steering Committee: AACR Report on the Impact of COVID-19 on Cancer Research and Patient Care
Antoni Ribas, MD, PhD, FAACRChairAACR President 2020-2021Professor of Medicine, Surgery, and Molecular & Medical PharmacologyDirector, Tumor Immunology ProgramUniversity of...
Cancer Policy Monitor: March 8, 2022
Biden Announces Reignited Cancer Moonshot Appropriations Update from Capitol Hill Dr. Robert M. Califf Sworn in as Commissioner of...
The AACR Call to Action
Decades of investment in basic, translational, and clinical research have enabled scientists to develop COVID-19 diagnostics, treatments, and vaccines...
AACR Cancer Policy Monitor: April 12, 2022
Fiscal Year 2023 Budget is Released Appropriations Update National Cancer Institute Director Sharpless Steps Down House Subcommittee Takes Aim...
Landmarks in Cancer Research: 2011-Present
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 References
Cancer Policy Monitor: December 13, 2022
Appropriations Update -Marc B. Johnson, MPP House and Senate Appropriations Committee leaders are in negotiations to finalize a bipartisan...
AACR Timeline—At the Forefront of Cancer Science in the 21st Century: 2000-Present
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018...
Larry Saltzman, MD: Participating in a Clinical Trial for CAR T-cell Therapy During a Global Pandemic
Age 68Sacramento, California Since his diagnosis with chronic lymphocytic leukemia in January 2010, life for Larry Saltzman, a board-certified...
Cancer Policy Monitor: January 11, 2022
House passes PREVENT HPV Cancers Act AACR Submits Public Comments to Encourage CMS to Reimburse Providers for Smoking Cessation...
History of the AACR
The following narrative describes over 100 years of AACR history. From the simple beginning of a few scientists gathering...
Cancer Policy Monitor: February 8, 2022
Appropriations Update from Capitol Hill Register Today! Virtual Congressional Briefing to Release AACR’s Report on COVID-19 and Cancer No...
Cancer Policy Monitor: April 8, 2025
Congress Passes Full-Year Spending Bill with Flat NIH and NCI Funding -Matt Gontarchick On March 15, President Donald Trump...
Cancer Policy Monitor: December 10, 2024
Appropriations Update -Matt Gontarchick Negotiations remain underway on Fiscal Year (FY) 2025 appropriations in the wake of the 2024...
Cancer Policy Monitor: July 8, 2025
Senators Question NIH Director on Proposed Cuts to NIH in FY2026 Budget -Matt Gontarchick National Institutes of Health (NIH)...
Rachel Orth: Navigating a Clinical Trial for Metastatic Gastric Cancer During the Pandemic
Age 33Arlington, Texas During Rachel Orth’s annual well-woman checkup in November 2020, a mass was discovered on her ovary....
Cancer Policy Monitor, November 8, 2022
AACR and ASCO Publish Updated E-Cigarette Policy Statement -Nicholas Warren, PhD In 2015, the American Association for Cancer Research...